Loading…
LifeStance Health Group, Inc. is projected to rise to $15.95 by 2027, a +49% move from its current price of $10.71. LFST is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $10.44 | $10.71 | $10.99 | +0.06% |
| Jul 14 | $10.34 | $10.72 | $11.11 | +0.12% |
| Jul 15 | $10.26 | $10.72 | $11.21 | +0.18% |
| Jul 16 | $10.20 | $10.73 | $11.29 | +0.24% |
| Jul 17 | $10.14 | $10.74 | $11.37 | +0.29% |
| Jul 18 | $10.09 | $10.74 | $11.44 | +0.35% |
| Jul 19 | $10.05 | $10.75 | $11.50 | +0.41% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.05 | $10.75 | $11.50 | +0.41% |
| Week 2 | $9.81 | $10.79 | $11.87 | +0.83% |
| Week 3 | $9.64 | $10.84 | $12.18 | +1.24% |
| Week 4 | $9.51 | $10.88 | $12.46 | +1.66% |
| Week 5 | $9.40 | $10.93 | $12.71 | +2.08% |
| Week 6 | $9.30 | $10.97 | $12.95 | +2.50% |
| Week 7 | $9.22 | $11.02 | $13.17 | +2.93% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc.
was founded in 2017 and is headquartered in Scottsdale, Arizona.
LifeStance Health Group, Inc. (LFST) is a healthcare company with a current price of $10.49 and a market cap of $4.01B. It ranks 1539 by market capitalization.
The near-term outlook shows a forecasted path for 2026 with an average price of $10.49, a min of $6.24, and a max of $14.76; the ROI is 0 and the sentiment is NEUTRAL.
Beyond 2026, the forecast depicts bullish momentum with rising averages and positive ROIs through 2035, then into 2040 and 2050. Notably, the 2030 average is $23.25, the 2040 average is $91.14, and the 2050 average is $176.20, indicating meaningful long-term upside alongside ongoing volatility and risk.
A major floor 46.4% below — a decisive break under it would weaken the trend.
The nearest floor, 31.4% below — buyers have tended to step in here.
The nearest ceiling, 6.8% above — a clean break opens room to run.
A major ceiling 30.0% above — clearing it would confirm fresh momentum.
Key LFST support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LFST market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.78 | Sell | $10.75 | Sell |
| MA 10 | $10.79 | Sell | $10.56 | Buy |
| MA 20 | $9.90 | Buy | $9.99 | Buy |
| MA 50 | $8.56 | Buy | $8.89 | Buy |
| MA 100 | $7.66 | Buy | $8.07 | Buy |
| MA 200 | $6.99 | Buy | $7.35 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 66.61 | Neutral |
| Stoch RSI (14) | 5.09 | Buy |
| CCI (20) | 60.20 | Neutral |
| Williams %R (14) | -32.58 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 13.40 | Buy |
| Bollinger %B (20,2) | 0.70 | Neutral |
| Stochastic %K (14) | 67.42 | Neutral |
| TRIX (15) | 1.28 | Buy |
| Awesome (5,34) | 1.82 | Buy |
| Ultimate (7,14,28) | 59.58 | Neutral |
| Momentum (10) | 0.82 | Buy |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 10.63 | Buy |
| ADX (14) | 38.98 | Buy |
| ATR (14) | 0.25 | Info |
The 30-day technical picture is bullish, with RSI14 at 70. Price is above both the SMA50 of $8.43 and the SMA200 of $6.94, signaling positive near-term momentum.
The 30-day range spans from $8.81 to $12.49, with a support level at $7.34 and a resistance level at $11.43. Annualized volatility is 50%, underscoring notable price movement potential within the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $6.24 | $10.71 | $14.93 | 0% | Neutral | |
| $12.78 | $15.95 | $21.02 | +49% | Bullish | |
| $14.08 | $18.04 | $24.62 | +69% | Bullish | |
| $16.14 | $21.13 | $29.63 | +97% | Bullish | |
| $17.72 | $23.64 | $33.93 | +121% | Bullish | |
| $19.86 | $26.94 | $39.45 | +152% | Bullish | |
| $24.21 | $33.39 | $49.77 | +212% | Bullish | |
| $28.79 | $40.30 | $61.08 | +276% | Bullish | |
| $33.06 | $46.93 | $72.21 | +338% | Bullish | |
| $36.11 | $51.97 | $81.08 | +385% | Bullish | |
| $60.20 | $92.11 | $152.42 | +760% | Bullish | |
| $104.66 | $177.83 | $320.69 | +15.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $6.24 | $10.71 | $12.75 | +0.00% |
| August 2026 | $9.19 | $10.83 | $13.09 | +1.15% |
| September 2026 | $9.52 | $11.30 | $13.79 | +4.32% |
| October 2026 | $9.70 | $11.56 | $14.25 | +2.38% |
| November 2026 | $9.64 | $11.55 | $14.34 | -0.09% |
| December 2026 | $9.93 | $11.95 | $14.93 | +3.39% |
Click any year to see its month-by-month LFST forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
LifeStance Health Group, Inc.'s 2026 outlook centres on $10.71, within a $6.24 to $14.93 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, LFST could reach as high as $21.02, with a base case around $15.95 and support toward $12.78 — roughly +49% from $10.71. Buyers look set to stay in control over this stretch.
Expect LFST to range from $14.08 to $24.62 through 2028. The $18.04 average target implies a +69% move from current prices. That is up +13% on the projected 2027 average. Momentum favours further upside here.
The LFST price prediction for 2029 points to an average of $21.13 (low $16.14, high $29.63) — a potential gain of +97% on today's $10.71. Buyers look set to stay in control over this stretch.
In 2030, LFST is projected to trade between $17.72 and $33.93, averaging $23.64 — a potential gain of +121% from today's $10.71. That is up +12% on the projected 2029 average. Momentum favours further upside here.
LifeStance Health Group, Inc.'s 2031 outlook centres on $26.94, within a $19.86 to $39.45 range. That is up +14% on the projected 2030 average. That marks a +152% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, LFST could reach as high as $49.77, with a base case around $33.39 and support toward $24.21 — roughly +212% from $10.71. Momentum favours further upside here.
Expect LFST to range from $28.79 to $61.08 through 2033. The $40.30 average target implies a +276% move from current prices. That is up +21% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The LFST price prediction for 2034 points to an average of $46.93 (low $33.06, high $72.21) — a potential gain of +338% on today's $10.71. Momentum favours further upside here.
In 2035, LFST is projected to trade between $36.11 and $81.08, averaging $51.97 — a potential gain of +385% from today's $10.71. That is up +11% on the projected 2034 average. Buyers look set to stay in control over this stretch.
LifeStance Health Group, Inc.'s 2040 outlook centres on $92.11, within a $60.20 to $152.42 range. That is up +77% on the projected 2035 average. That marks a +760% change versus current levels. Momentum favours further upside here.
By 2050, LFST could reach as high as $320.69, with a base case around $177.83 and support toward $104.66 — roughly +15.6x from $10.71. Buyers look set to stay in control over this stretch.
Investing $1,000 in LFST today (≈ 93.414292 LFST) could be worth
$16,611.88
+$15,611.88 (+1561%) by 2050 · US Dollar
Based on the average projected LFST price of $177.83 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LFSTwould be worth at today's price.
$1,000 invested in LFST on Jul 10, 2025 (≈ 211.41649 LFST) would be worth
$2,263.21
+$1,263.21 (+126.3%) today · 2.26× · US Dollar
Based on a LFST entry price of $4.73 vs. today's $10.71.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.27 | $949.87 | -5.0% |
| 1 month ago | $7.86 | $1,361.96 | +36.2% |
| 3 months ago | $6.4 | $1,672.66 | +67.3% |
| 6 months ago | $7.46 | $1,434.99 | +43.5% |
| 1 year ago | $4.73 | $2,263.21 | +126.3% |
| All time (5.0y) ago | $28.01 | $382.18 | -61.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LFST forecast.
Our base-case forecast reaches $21.00 around 2029.
Implied market cap at $21.00: $8.02B
The multi-year forecast points to a gradual upward trajectory with evolving sentiment. For 2026, the average price is $10.49 with ROI 0 and sentiment NEUTRAL.
From 2027 onward, the outlook is BULLISH with rising averages: 2027 avg $15.74, ROI 50; 2028 avg $17.69, ROI 68.7; 2029 avg $20.83, ROI 98.5; 2030 avg $23.25, ROI 121.6; 2031 avg $26.40, ROI 151.7. The trend continues with 2032 avg $33.00, ROI 214.6; 2033 avg $39.78, ROI 279.2; 2034 avg $46.32, ROI 341.6; 2035 avg $51.54, ROI 391.4.
Looking further out, 2040 is forecast to average $91.14 with ROI 768.8 and a bullish sentiment, while 2050 is forecast to average $176.20 with ROI 1579.7 and a bullish sentiment as well. These figures represent estimates and are not guarantees, given the inherent uncertainty and range of potential market outcomes.
Tap a question to reveal the answer.
2030 avg $23.25, min $17.33, max $33.59, ROI 121.6, sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages and positive ROIs, including 2027 ROI 50, 2028 ROI 68.7, 2029 ROI 98.5, and 2030 ROI 121.6.
Yes. The forecast includes a 2040 max of $152.42 and a 2050 max of $321.79, indicating prices well above $100 are possible in the forecast horizon.
The 2026 forecast shows min $6.24, avg $10.49, max $14.76 with ROI 0 and sentiment NEUTRAL.
2050 avg $176.20, min $101.94, max $321.79, ROI 1579.7, sentiment BULLISH.
LifeStance Health Group, Inc. Community Discussion
0Share your LifeStance Health Group, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.